The hugely popular weight-loss drug Wegovy has been approved in China, Novo Nordisk said on Tuesday, the world’s second-largest economy and the country estimated to hold the highest number of overweight or obese people.
The company announced plans to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
Susan Perlbachs of EVERSANA INTOUCH offers an inside look at serving on the Cannes Lions Health 2024 Pharma Jury.
In this new role at Real Chemistry, Pudloski will serve as a strategic advisor to clients and bring her experience and expertise across the entire healthcare ecosystem to develop innovative data-driven solutions to solve clients’ greatest challenges.
Whether you love or hate the Request for Proposal (RFP)/ “pitch” process, it’s still the industry standard for getting to know potential agency partners.
The company unveiled detailed findings from the Phase III SURMOUNT-OSA program, showing that its blockbuster weight-loss drug Zepbound (tirzepatide) could significantly improve disease severity in patients with moderate-to-severe obstructive sleep apnea and obesity.